Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Choy

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Journal of Surgical Oncology|October 30, 2016
Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomasKaren De Amorim Bernstein, Norbert Liebsch, Yen-Lin Chen, et al.
Annals of Surgical Oncology|September 12, 2012
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical seriesJohn T Mullen, Thomas F Delaney, Wendy K Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Sujana Movva, Sahar Matloob, Elizabeth A Handorf, et al.
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L Haddox, Michael J Nathenson, Emanuele Mazzola, et al.
Skeletal Radiology|March 21, 2026
Soft tissue reporting and data system (soft tissue-RADS): framework for radiologists specializing in imaging of musculoskeletal tumors and tumor-like lesionsAvneesh Chhabra, Mark D Murphey, Mahad Rehman, et al.
The Oncologist|August 21, 2013
β-Catenin mutation status and outcomes in sporadic desmoid tumorsJohn T Mullen, Thomas F DeLaney, Andrew E Rosenberg, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|April 17, 2012
Establishment and characterization of a novel chordoma cell line: CH22Xianzhe Liu, Gunnlager Petur Nielsen, Andrew E Rosenberg, et al.
Lancet (London, England)|February 15, 2016
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trialPatrick Schöffski, Sant Chawla, Robert G Maki, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Journal of Surgical Oncology|October 30, 2016
Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomasKaren De Amorim Bernstein, Norbert Liebsch, Yen-Lin Chen, et al.
Annals of Surgical Oncology|September 12, 2012
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical seriesJohn T Mullen, Thomas F Delaney, Wendy K Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Sujana Movva, Sahar Matloob, Elizabeth A Handorf, et al.
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L Haddox, Michael J Nathenson, Emanuele Mazzola, et al.
Skeletal Radiology|March 21, 2026
Soft tissue reporting and data system (soft tissue-RADS): framework for radiologists specializing in imaging of musculoskeletal tumors and tumor-like lesionsAvneesh Chhabra, Mark D Murphey, Mahad Rehman, et al.
The Oncologist|August 21, 2013
β-Catenin mutation status and outcomes in sporadic desmoid tumorsJohn T Mullen, Thomas F DeLaney, Andrew E Rosenberg, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|April 17, 2012
Establishment and characterization of a novel chordoma cell line: CH22Xianzhe Liu, Gunnlager Petur Nielsen, Andrew E Rosenberg, et al.
Lancet (London, England)|February 15, 2016
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trialPatrick Schöffski, Sant Chawla, Robert G Maki, et al.
Pageof 18